Clincosm LogoSign in Get a demo

primary sclerosing cholangitis

Showing 1 - 25 of 80
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Primary Sclerosing Cholangitis Trial (Aramchol meglumine)

Not yet recruiting
  • Primary Sclerosing Cholangitis
  • Aramchol meglumine
  • (no location specified)
Oct 17, 2023

TruGraf Liver Gene Expression Serial Test

Not yet recruiting
  • Autoimmune Liver Disease
  • +3 more
  • TruGraf®
  • (no location specified)
Sep 27, 2023

Primary Sclerosing Cholangitis, Ulcerative Colitis, Biliary Tract Diseases Trial in Prague (Gluten-free diet)

Recruiting
  • Primary Sclerosing Cholangitis
  • +4 more
  • Gluten-free diet
  • Prague, Czechia
    Institute of clinical and experimental medicine
Sep 6, 2023

Primary Sclerosing Cholangitis, IBD Trial in Stanford (Rosuvastatin)

Recruiting
  • Primary Sclerosing Cholangitis
  • Inflammatory Bowel Diseases
  • Stanford, California
    Stanford University
Jun 12, 2023

Primary Sclerosing Cholangitis Trial in Shanghai (CS0159 2mg, Placebo)

Not yet recruiting
  • Primary Sclerosing Cholangitis
  • CS0159 2mg
  • Placebo
  • Shanghai, Shanghai, China
    Renji Hospital, Shanghai Jiao Tong University School of Medicine
Jun 7, 2023

Primary Sclerosing Cholangitis, Liver and Intrahepatic Bile Duct Disorder, IBD Trial in Monza (Oral Vancomycin, Placebo)

Recruiting
  • Primary Sclerosing Cholangitis
  • +2 more
  • Oral Vancomycin
  • Placebo
  • Monza, Monza E Brianza, Italy
    Fondazione IRCCS San Gerardo dei Tintori
May 16, 2023

Primary Sclerosing Cholangitis Trial in Seoul (HK-660S, Placebo)

Active, not recruiting
  • Primary Sclerosing Cholangitis
  • Seoul, Korea, Republic of
  • +3 more
May 10, 2023

Primary Sclerosing Cholangitis Trial (BRS201, Placebo)

Not yet recruiting
  • Primary Sclerosing Cholangitis
  • (no location specified)
Apr 18, 2023

Autoimmune Hepatitis, Primary Sclerosing Cholangitis Trial in United States (No interventions)

Recruiting
  • Autoimmune Hepatitis
  • Primary Sclerosing Cholangitis
  • No interventions
  • Palo Alto, California
  • +4 more
Feb 28, 2023

Primary Sclerosing Cholangitis Trial in Paris, Monza, Barcelona (A3907)

Recruiting
  • Primary Sclerosing Cholangitis
  • Paris, France
  • +2 more
Jan 27, 2023

Biliary Cell-derived Organoids From Bile of PSC and Non-PSC

Recruiting
  • Primary Sclerosing Cholangitis
  • +2 more
    • Rochester, Minnesota
      Mayo Clinic in Rochester
    Jan 9, 2023

    Primary Sclerosing Cholangitis Trial (Elafibranor 80 mg, Elafibranor 120 mg, Placebo Matched to Elafibranor 80 mg)

    Not yet recruiting
    • Primary Sclerosing Cholangitis
    • Elafibranor 80 mg
    • +3 more
    • (no location specified)
    Dec 27, 2022

    National Database on Primary Sclerosing Cholangitis (PSC)

    Recruiting
    • Primary Sclerosing Cholangitis
    • Clinical information
    • Ancona, Italy
    • +62 more
    Nov 8, 2022

    Primary Sclerosing Cholangitis Trial in Redwood City, Stanford (Hymecromone)

    Not yet recruiting
    • Primary Sclerosing Cholangitis
    • Redwood City, California
    • +1 more
    Nov 1, 2022

    Primary Sclerosing Cholangitis Trial in Phoenix, Tempe, Rochester (Vidofludimus calcium)

    Completed
    Has Results
    • Primary Sclerosing Cholangitis
    • Vidofludimus calcium
    • Phoenix, Arizona
    • +2 more
    Oct 11, 2022

    Underlying Primary Sclerosing Cholangitis

    Recruiting
    • Primary Sclerosing Cholangitis
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Aug 17, 2022

      Primary Sclerosing Cholangitis, Autoimmune Hepatitis, Overlap Syndrome Trial in Brussel (Metronidazole)

      Completed
      • Primary Sclerosing Cholangitis
      • +2 more
      • Brussel, Bruxelles, Belgium
        Cliniques Universitaires Saint-Luc - Université Catholique de Lo
      Aug 4, 2022

      Primary Sclerosing Cholangitis Trial in Worldwide (Volixibat, Placebo)

      Recruiting
      • Primary Sclerosing Cholangitis
      • Coronado, California
      • +36 more
      Jul 29, 2022

      Multicenter Observational Study of PSC and IgG4-SC in China

      Recruiting
      • Primary Sclerosing Cholangitis
      • IgG4-related Sclerosing Cholangitis
      • Only observation
      • Shanghai, 上海市, China
        RenJi Hospital
      Jul 18, 2022

      Primary Sclerosing Cholangitis Trial (Liver Multiscan sequences, Liver Multiscan analysis, MRCP+)

      Not yet recruiting
      • Primary Sclerosing Cholangitis
      • Liver Multiscan sequences
      • +2 more
      • (no location specified)
      Jul 13, 2022

      Host and Microbial Mechanisms and Druggable Targets for

      Recruiting
      • Inflammatory Bowel Diseases
      • Primary Sclerosing Cholangitis
      • Oral Vancomycin
      • Birmingham, United Kingdom
        University Hospitals Birmingham NHS Foundation Trust
      May 27, 2022

      Idiopathic Pulmonary Fibrosis, Primary Sclerosing Cholangitis, Covid19 Pneumonia Trial in Stanford ([18F]FP-R01-MG-F2)

      Recruiting
      • Idiopathic Pulmonary Fibrosis
      • +2 more
      • Stanford, California
        Stanford University
      May 3, 2022

      Primary Sclerosing Cholangitis in Children

      Recruiting
      • Primary Sclerosing Cholangitis
      • +2 more
        • Los Angeles, California
        • +11 more
        Mar 9, 2022

        Primary Sclerosing Cholangitis Trial in United States (Sulfasalazine, Placebo)

        Recruiting
        • Primary Sclerosing Cholangitis
        • Davis, California
        • +11 more
        Mar 4, 2022

        Primary Sclerosing Cholangitis, Primary Biliary Cirrhosis, Cholangiocarcinoma Trial in Rochester

        Recruiting
        • Primary Sclerosing Cholangitis
        • +3 more
          • Rochester, Minnesota
            Mayo Clinic
          Feb 22, 2022